Anticoagulant therapy in a patient with a history of cerebral hemorrhage
Several guidelines recommend the preferential use of NOAC compared to warfarin in patients with atrial fibrillation, based on evidence to support a efficacy similar to warfarin, but with a lower incidence of intracranial hemorrhage. The case described is a typical example of non-optimal use of NOACs...
Main Author: | Mario Crisci |
---|---|
Format: | Article |
Language: | English |
Published: |
AboutScience Srl
2018-11-01
|
Series: | AboutOpen |
Subjects: | |
Online Access: | https://journals.aboutscience.eu/index.php/aboutopen/article/view/130 |
Similar Items
-
Oral anticoagulant therapy in a patient with CHA₂DS₂-VASc score 1
by: Stefania Cherubini, et al.
Published: (2018-11-01) -
Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia
by: C. L. Shovlin, et al.
Published: (2019-08-01) -
Factors driving the use of warfarin and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
by: Mu-Mei Hu, et al.
Published: (2017-04-01) -
Efficacy and safety of novel anticoagulant dabigatran in clinical practice for Japanese patients with non-valvular atrial fibrillation
by: Koji Miyamoto, et al.
Published: (2014-02-01) -
Efficacy and safety of new oral anticoagulants compared with warfarin in cardioembolic prophylaxis of patients with non valvular atrial fibrillation. More lights than shadows
by: Luca Masotti, et al.
Published: (2012-10-01)